Scientific Resources

AllNewsTechnical Articles

News

10/23/2023

We are recruiting a ISO 13485 Quality Assurance / Regulatory Affairs Manager

You will be responsible for managing and adapting the quality system to meet the various standards required for international commercialization (ISO 13485, MDR 2017/745, MDSAP, FDA 21 CFR 820...), as well as preparing the necessary documentation for registrations outside Europe...

Technical Articles

10/23/2023

Alleviating the burden of PACG treatment

Primary angle-closure glaucoma (PACG) represents a significant cause of blindness, affecting more than 17 million people worldwide. Moreover, the currently available treatment options for the management PACG remain relatively limited. The cilioscleral inter-positioning device is a novel minimally invasive implant designed to increase uveoscleral outflow without entering the chamber. This unique approach to lower IOP represents a new, efficient, and safe surgical option to reduce intraocular pressure for patients with PACG.

News

09/07/2023

Preliminary one-year study results on treating open and narrow angle glaucoma with CID

Ciliatech presents preliminary one-year study results on treating open and narrow angle glaucoma with CID at Ophthalmology Futures Symposium.

News

08/09/2023

Ophthalmology Times Europe

At the World Glaucoma Congress (WGC) in Rome, Italy this summer, Ciliatech presented preliminary results of the second 2-year postoperative clinical trial (SAFARI Ⅱ) on its Cilioscleral Interposition Device (CID).

Technical Articles

07/19/2023

How the cilioscleral approach fits in with other glaucoma surgical techniques

Glaucoma is a group of progressive, neurodegenerative eye diseases associated with irreversible optic neuropathy followed by visual-field impairment. Epidemiological estimates suggest that the most common form,

News

06/28/2023

Two-year post-operative results on new cilio-scleral surgical approach for treating glaucoma

Results from second CID (Cilio-scleral Interposition Device) study confirm sustained decrease in intraocular pressure (IOP), while preserving anterior chamber of eye

News

05/17/2023

Ciliatech is recruiting a Clinical Affairs Manager

You will be the 2nd employee of the Company, reporting directly to the CEO, and in close connection withe the medical Director...

News

04/25/2023

Ciliatech raises €3.5M in Series A funding

Funds will advance development of Ciliatech’s disruptive glaucoma implant CID and initiate clinical trials in Europe, paving way for CE mark approval

News

03/29/2023

Positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow-up

Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow-up. Data support sustained safety and performance of first generation glaucoma implant CID (Cilio-scleral Interpositioning Device)...